Peritoneal cancer Market

Request Customization

Peritoneal cancer Market Research Report - Size, Share, Growth, and Trend Analysis | Forecast (2025 - 2030)

Published: 2025 - Mar

Report Code: VMR-18331

Region: Global

Historic Range: 2022-2024

Forecast: 2025-2031

Format: Excel and PDF

Peritoneal cancer Market (2025-2030)

Peritoneal cancer is a rare but aggressive malignancy originating in the peritoneum, the thin layer of tissue lining the abdomen. It shares histological and clinical similarities with ovarian cancer, often leading to late-stage diagnoses and limited treatment options. Advances in molecular profiling, immunotherapy, and precision medicine are reshaping therapeutic landscapes, improving patient outcomes through targeted interventions and innovative drug combinations.

Disruptive Impact and Opportunities:
The market is witnessing transformative changes driven by novel antibody-drug conjugates, next-generation immunotherapies, and innovative targeted therapies. These advancements enable earlier detection and more effective treatment strategies, addressing an unmet need in a traditionally challenging oncology segment. Emerging therapeutics such as Luvelta (STRO-002), IMGN151, and Catumaxomab offer groundbreaking approaches that improve safety profiles and therapeutic efficacy. The integration of AI-driven diagnostics and biomarker-driven therapies streamlines treatment decision-making, making personalized medicine more accessible.

Emerging Drugs:

Luvelta (STRO-002)
IMGN151
Catumaxomab

Marketed Drugs:

Zejula
Avastin
Bevacizumab
Niraparib
Mvasi
Elahere
Alymsys

Key Companies:

Shattuck Labs, Inc.
Corcept Therapeutics
Seagen
Mersana Therapeutics
IMPACT Therapeutics
ImmunoGen
LintonPharm Co., Ltd.
Sutro Biopharma, Inc.
Elucida Oncology
Bio-Path Holdings
Clover Biopharmaceutical AUS Pty Ltd
Rhizen Pharmaceuticals SA
Oncoinvent
OncoMed Pharmaceuticals, Inc.
Ipsen
Green3Bio

Market Segmentation:

By Type

Primary Peritoneal Cancer
Secondary Peritoneal Cancer
- Peritoneal Carcinomatosis
- Peritoneal Mesothelioma
- Peritoneal Sarcomatosis

By Administration Type

Oral
Intravenous (IV)
Intraperitoneal (IP)
Subcutaneous (SC)

What’s in It for You?

Comprehensive insights into emerging and marketed therapeutics
Strategic analysis of competitive dynamics and key market players
Evaluation of novel treatment modalities and clinical advancements
Identification of investment opportunities in breakthrough oncology innovations
Data-driven recommendations for informed decision-making in R&D and commercialization

📥 Download Sample Report

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

4250

Multi User

5250

Corporate User

6900

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe